Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Arcadia Biosciences, Inc. (RKDA) had Revenue of $1.20M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$1.20M
Net Income	$2.60M
Cost of Goods Sold	$0.68M
Gross Profit	$0.52M
Operating Expenses	$0.67M
Operating Income	$0.53M
Non-Operating Income/Expense	$2.07M
Pre-Tax Income	$2.60M
Normalized Pre-Tax Income	$2.60M
Income after Taxes	$2.60M
Income from Continuous Operations	$2.60M
Consolidated Net Income/Loss	$2.60M
Normalized Income after Taxes	$2.60M
EBIT	$0.53M
EBITDA	$0.58M
Weighted-Average Shares Outstanding (Basic)	1.37M
Weighted-Average Shares Outstanding (Diluted)	1.37M
Earnings per Share (EPS) (Basic)	$1.90
Earnings per Share (EPS) (Diluted)	$1.90
Balance Sheet Financials
Current Assets	$8.85M
Property, Plant, and Equipment	$0.03M
Long-Term Assets	$4.14M
Total Assets	$12.99M
Current Liabilities	$2.22M
Long-Term Debt	--
Long-Term Liabilities	$1.87M
Total Liabilities	$4.08M
Common Equity	$8.90M
Tangible Shareholders Equity	$8.87M
Shareholders Equity	$8.90M
Common Shares Outstanding	1.37M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-1.59M
Cash Flow from Investing Activities	$0.50M
Cash Flow from Financial Activities	$0.01M
Beginning Cash	$4.24M
End Cash	$3.16M
Increase/Decrease in Cash	$-1.08M
Stock-Based Compensation	$0.08M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.99
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	43.17%
Operating Margin	44.17%
EBIT Margin	44.17%
EBITDA Margin	--
Pre-Tax Profit Margin	216.58%
Profit Margin	216.58%
Free Cash Flow	$-1.59M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.53
Receiveable Turnover	0.74
Days Sales in Receivables	121.12
Return on Equity	29.19%
Return on Tangible Equity	29.31%
Return on Assets	20.01%
Return on Investments	29.19%
Book Value Per Share	$6.51
Free Cash Flow per Share	$-1.16
Operating Cash Flow per Share	$-1.16

Data from Zacks Investment Research, Inc.